STONEPINE CAPITAL MANAGEMENT, LLC
other names
- STONEPINE CAPITAL MANAGEMENT, LLC
Adviser Profile
| As of Date | 03/30/2026 |
| Registration | SEC, Approved, 08/01/2017 |
|
|
|
| Former registrations | |
| ADV Location | BEND, OR, United States |
| Contact Info | 541 xxxxxxx |
| Websites |
|
Exempt Reporting Adviser
2B(3)- PF>150mn
|
|
| Private Fund GAV* | 191,601,618 45% |
| SMA’s | No |
| Private Funds | 1 |
Private Funds
Employees
Private Funds Structure
| SEC Fund Type | Count | GAV |
|---|---|---|
| Fund TypeHedge Fund | Count1 | GAV$191,601,618 |
Top Holdings
| Stock Ticker | Stock Name | $ Position | % Position | $ Change | # Change |
|---|---|---|---|---|---|
| Stck Ticker78464A870 | Stock NameSPDR SERIES TRUST (PUT) | $ Position$51,092,000 | % Position20.00% | $ Change | # Change |
| Stck Ticker78464A870 | Stock NameSPDR SERIES TRUST (CALL) | $ Position$51,092,000 | % Position20.00% | $ Change | # Change |
| Stck Ticker92337C203 | Stock NameVERASTEM INC | $ Position$17,502,190 | % Position7.00% | $ Change-17.00% | # Change21.00% |
| Stck Ticker88032L605 | Stock NameTENAX THERAPEUTICS INC | $ Position$15,593,448 | % Position6.00% | $ Change10664.00% | # Change8106.00% |
| Stck Ticker000899104 | Stock NameADMA BIOLOGICS INC (CALL) | $ Position$10,361,500 | % Position4.00% | $ Change | # Change |
| Stck Ticker30052C107 | Stock NameEVOLUS INC | $ Position$7,229,864 | % Position3.00% | $ Change-33.00% | # Change8.00% |
| Stck Ticker000899104 | Stock NameADMA BIOLOGICS INC | $ Position$6,667,400 | % Position3.00% | $ Change-51.00% | # Change0.00% |
| Stck Ticker880881107 | Stock NameTERNS PHARMACEUTICALS INC (CALL) | $ Position$5,272,000 | % Position2.00% | $ Change | # Change |
| Stck Ticker640268306 | Stock NameNEKTAR THERAPEUTICS | $ Position$6,115,750 | % Position2.00% | $ Change70.00% | # Change0.00% |
| Stck Ticker13463J101 | Stock NameCAMP4 THERAPEUTICS CORP | $ Position$6,128,233 | % Position2.00% | $ Change337.00% | # Change507.00% |